Advertisement
Screener

Bolt Biotherapeutics, Inc. (BOLT) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Bolt Biotherapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Bolt Biotherapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $39.85M went out.
  • Fiscal year ended 2025-12-31: from investing, $44.30M came in.
  • Fiscal year ended 2025-12-31: from financing, $19.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.47M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$39.85M$44.30M$19.00K$4.47M
2024-12-31-$61.29M$57.58M$108.00K-$3.60M
2023-12-31-$69.53M$71.04M$253.00K$1.77M
2022-12-31-$76.50M$57.86M$503.00K-$18.14M
2021-12-31-$57.07M-$232.20M$1.25M$309.86M*$21.84M
2020-12-31-$47.31M-$20.59M$294.00K$39.30M*-$28.30M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$6.54M*$7.77M*$19.00K*
2026-03-31-$8.02M$7.92M$6.00K-$94.00K
2025-12-31-$7.16M*$1.07M*$5.00K*
2025-09-30-$9.73M*$17.88M*$0.00*
2025-06-30-$9.60M*$10.79M*$14.00K*
2025-03-31-$13.37M$14.55M$0.00$1.19M
2024-12-31-$14.43M*$12.23M*$29.00K*
2024-09-30-$13.97M*$17.14M*$0.00*
2024-06-30-$16.14M*$18.00M*
2024-03-31-$16.75M$10.20M-$6.55M
2023-12-31-$14.27M*$15.81M*$106.00K*
2023-09-30-$16.75M*$12.66M*$0.00*
2023-06-30-$15.11M*$13.58M*
2023-03-31-$23.40M$28.99M$5.59M
2022-12-31-$17.95M*$16.43M*$144.00K*
2022-09-30-$13.45M*$1.45M*$0.00*
2022-06-30-$20.79M*-$868.00K*$252.00K*
2022-03-31-$24.31M$40.84M$107.00K$16.64M
2021-12-31-$17.79M*$21.03M*$495.00K*
2021-09-30-$18.73M*-$16.11M*$185.00K*
2021-06-30-$3.99M*-$46.60M*$443.00K*$12.97M*
2021-03-31-$16.56M-$190.52M$129.00K$296.89M*$89.94M
2020-12-31-$12.89M*$1.70M*$78.00K*-$1.14M*
2020-09-30-$12.52M*-$13.10M*$177.00K*-$1.10M*
2020-06-30-$12.27M*$4.41M*$5.00K*$41.55M*
2020-03-31-$9.64M-$13.61M$34.00K-$23.21M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63
SYNLOGIC, INC. (SYBX)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Ernexa Therapeutics Inc. (ERNA)United States$0.006B
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Pulmatrix, Inc. (PULM)United States$0.006B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
EXICURE, INC. (XCUR)United States$0.008B-1.54